| |
| |
|
| Insider
Information: |
Rothblatt Martine A |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
130 |
|
|
Indirect Shares
|
647,065 |
|
|
| Direct
Value |
$35,474 |
|
|
|
Indirect Value
|
$176,571,097 |
|
|
| Total
Shares |
647,195 |
|
|
| Total
Value |
$176,606,572 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
United Therapeutics Corp |
UTHR |
|
2024-05-22 |
130 |
2024-05-22 |
647,065 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
2038 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 14 of 82
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2013-12-12 |
4 |
AS |
$89.94 |
$344,749 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2013-12-19 |
4 |
AS |
$87.25 |
$334,419 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2013-12-26 |
4 |
AS |
$111.59 |
$427,723 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-01-02 |
4 |
AS |
$111.54 |
$427,549 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-01-09 |
4 |
AS |
$108.35 |
$415,314 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-01-16 |
4 |
AS |
$111.21 |
$426,287 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-01-23 |
4 |
AS |
$111.78 |
$428,445 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-01-30 |
4 |
AS |
$106.25 |
$407,258 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-02-06 |
4 |
AS |
$97.26 |
$372,809 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-02-13 |
4 |
AS |
$99.87 |
$382,809 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-02-20 |
4 |
AS |
$103.91 |
$398,274 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-02-27 |
4 |
AS |
$100.68 |
$385,893 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-03-06 |
4 |
AS |
$102.77 |
$393,919 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-03-13 |
4 |
AS |
$95.64 |
$366,587 |
D/D |
(3,833) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-03-20 |
4 |
AS |
$96.55 |
$877,097 |
D/D |
(9,065) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-03-27 |
4 |
AS |
$92.27 |
$846,275 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-04-03 |
4 |
AS |
$93.14 |
$849,827 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-04-10 |
4 |
AS |
$95.29 |
$871,993 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-04-17 |
4 |
AS |
$96.93 |
$892,812 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-04-24 |
4 |
AS |
$92.25 |
$838,115 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-05-01 |
4 |
AS |
$99.21 |
$923,242 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-05-08 |
4 |
AS |
$105.79 |
$977,598 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-05-15 |
4 |
AS |
$100.68 |
$914,552 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-05-22 |
4 |
AS |
$100.07 |
$918,852 |
D/D |
(9,066) |
140 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2014-05-29 |
4 |
AS |
$95.21 |
$863,675 |
D/D |
(9,066) |
140 |
0 |
- |
|
2038 Records found
|
|
Page 14 of 82 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
